Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

(MedPage Today) -- Mepolizumab (Nucala) improved outcomes for adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and put about one in five on the way to remission, a real-life study from Italy showed. The nasal polyp score dropped...

Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Sunday 23 August →